Everads Therapy Enters Into Option Agreement With Global Pharma Company
Everads Therapy, developing the next generation of retinal treatment delivery technologies, today announced that it has signed an option agreement with a large global pharmaceutical company. This is Everads' first commercial agreement, and its signing supports the potential of its technology to overcome certain risks and side effects associated with current retinal disease treatment options.
REE Automotive to List on NASDAQ Through Merger with 10X Capital Venture Acquisition Corp
REE (SoftWheel) develops cutting edge systems for the automotive industry. Its innovative technology enables significant reduction in space, weight, and energy consumption of vehicle platforms for EV, hybrid, and autonomous vehicles.
Moebius and Sun Pharma sign osteoarthritis drug licensing deal
Israeli drug development company Moebius Medical has entered into an exclusive worldwide licensing deal with India's Sun Pharmaceutical Industries to develop MM-II, a novel pharmaceutical candidate for the treatment of osteoarthritis pain.
EON Surgical acquired by Teleflex
EON Medical was acquired by Teleflex in 2013. The company’s 2.9 mm Percuvance Percutaneous Surgical System was engineered to reduce trauma while delivering the performance previously offered only by 5 mm laparoscopic devices.
SteadyMed acquired by
United Therapeutics Corporation
SteadyMed is a pharmaceutical company focused on the development and commercialization of drug product candidates to treat orphan diseases with unmet parenteral delivery needs, was acquired by
United Therapeutics Corporation in 2018